Federal Practitioner

All SpecialtiesPRESENTED BY MDedge

CME Events
REGISTER or LOGIN

/

Federal Practitioner

ADVERTISEMENT

Exenatide vs Insulin Glargine for Body Fat and Cardiac Biomarker Effects

Federal Practitioner. 2010 November;27(11):42

November 1, 2010|Federal Practitioner

Author and Disclosure Information

Download Article

×

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

This Publication

Advertise
Contact Us
Corporate Management
Editorial Advisory Association
Editorial Policies
Multimedia
Submission Guidelines
Subscribe to Federal Practitioner

Facebook
Twitter

Top Sections

Best Practices
Government and Regulations
Original Research

Highlighted from this site and network

Digital Edition
Digital Supplements
Visual Abstracts

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

Copyright © 2026 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.